Ana Lucrecia Woodward

Array ( [id] => 9042395 [patent_doc_number] => 20130245033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'AMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/821165 [patent_app_country] => US [patent_app_date] => 2010-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10846 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278500 [patent_doc_number] => 20120172369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'INHIBITORS OF DIACYLGLYCEROL ACYLTRANSFERASE' [patent_app_type] => utility [patent_app_number] => 13/395589 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38462 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024208 [patent_doc_number] => 20110052534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Imidazopyridazine Compounds for Treating Viral Infections' [patent_app_type] => utility [patent_app_number] => 12/872443 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54269 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052534.pdf [firstpage_image] =>[orig_patent_app_number] => 12872443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6025927 [patent_doc_number] => 20110053892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections' [patent_app_type] => utility [patent_app_number] => 12/871107 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37994 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053892.pdf [firstpage_image] =>[orig_patent_app_number] => 12871107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8587153 [patent_doc_number] => 20130005974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'SYNTHESIS OF A NEUROSTIMULATIVE PIPERAZINE' [patent_app_type] => utility [patent_app_number] => 13/392489 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6457 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9086386 [patent_doc_number] => 08557815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Substituted triazolophthalazine derivatives' [patent_app_type] => utility [patent_app_number] => 12/856360 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14197 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12856360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10892945 [patent_doc_number] => 08916559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2, 4, 5-trifluorophenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluoromethyl)-1, 2, 4 -triazolo[4,3-A]pyrazin' [patent_app_type] => utility [patent_app_number] => 13/390039 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4765 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398451 [patent_doc_number] => 08268828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Inhibitors of the chemokine receptor CxCR3' [patent_app_type] => utility [patent_app_number] => 12/852076 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33415 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12852076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127966 [patent_doc_number] => 20110086863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/851466 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27459 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086863.pdf [firstpage_image] =>[orig_patent_app_number] => 12851466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6402140 [patent_doc_number] => 20100305127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/850386 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8224 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305127.pdf [firstpage_image] =>[orig_patent_app_number] => 12850386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629433 [patent_doc_number] => 20100311649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/849061 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46079 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311649.pdf [firstpage_image] =>[orig_patent_app_number] => 12849061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599793 [patent_doc_number] => 07977337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Quinoline derivatives and their use as 5-HT6 ligands' [patent_app_type] => utility [patent_app_number] => 12/847039 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15331 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977337.pdf [firstpage_image] =>[orig_patent_app_number] => 12847039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477830 [patent_doc_number] => 20120277238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING FUSED HETERO-RING DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/388296 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54779 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270386 [patent_doc_number] => 08211885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals' [patent_app_type] => utility [patent_app_number] => 12/845317 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38554 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12845317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633983 [patent_doc_number] => 20100311971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESULFONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE' [patent_app_type] => utility [patent_app_number] => 12/841195 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8479 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311971.pdf [firstpage_image] =>[orig_patent_app_number] => 12841195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5993890 [patent_doc_number] => 20110015393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'PHTHALAZINONE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/836903 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8424 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015393.pdf [firstpage_image] =>[orig_patent_app_number] => 12836903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710868 [patent_doc_number] => 08835436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same' [patent_app_type] => utility [patent_app_number] => 13/383143 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56260 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160719 [patent_doc_number] => 20120101277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'CRYSTALLINE FORM OF POSACONAZOLE' [patent_app_type] => utility [patent_app_number] => 13/379060 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5644 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101277.pdf [firstpage_image] =>[orig_patent_app_number] => 13379060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987201 [patent_doc_number] => 20110098308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'AZAINDAZOLE COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/829312 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51838 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098308.pdf [firstpage_image] =>[orig_patent_app_number] => 12829312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098497 [patent_doc_number] => 20110003994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'CYCLOALKANE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/828130 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7745 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003994.pdf [firstpage_image] =>[orig_patent_app_number] => 12828130 [rel_patent_id] =>[rel_patent_doc_number] =>)